A5068579134- Frailty in Older Adults
- Health Systems, Economic Evaluations, Quality of Life
- Palliative Care and End-of-Life Issues
- Cancer Genomics and Diagnostics
- Nutrition and Health in Aging
- Global Cancer Incidence and Screening
- Breast Cancer Treatment Studies
- Viral gastroenteritis research and epidemiology
- Cytomegalovirus and herpesvirus research
- Advances in Oncology and Radiotherapy
- Colorectal Cancer Surgical Treatments
- Herpesvirus Infections and Treatments
Kantonsspital Baselland
2024
Abstract Purpose To gather information from clinicians on how geriatric oncology models of care have emerged in different European countries and describe current practice this clinical area. Methods A semi-structured online interview was performed, exploring aspects related to implementation, perceived quality care, professional satisfaction. Results The centers participating showed significant differences terms resource allocation, team members, components the comprehensive assessment...
A 60-year-old female patient with longstanding left-sided ulcerative colitis presented symptoms mimicking an acute flare and developed a colonic perforation shortly after starting steroid treatment. Following left hemicolectomy Hartmann's procedure, rescue treatment infliximab was started. Within few days, the hepatic failure. Histology immunohistochemistry of specimen revealed extensive necrotizing herpes simplex virus colitis, liver biopsy demonstrated hepatitis. Sixteen days admission,...
Cancer is a common health problem in the older population. In Switzerland, more than 40,000 patients are diagnosed with cancer every year, majority 65 years. Because often excluded from clinical trials, optimal treatment for this population needs to be considered prevent over- or under-treatment. Several international guidelines provide recommendations special care of and frail patients, focus on addressing comorbidities care. many countries, including USA, Belgium, France Netherlands,...
In early luminal breast cancer, the Oncotype DX® Recurrence Score (RS) prognostic and predictive value with regards to chemotherapy (CHT) application benefit has been broadly validated. older patients its not deeply addressed. This study aimed evaluate benefits of RS testing look at differences in treatment allocation for these when compared younger ones.We included data from consecutive HER2-negative treated between 2010 2022 University Hospital Basel Cantonal Baselland, Switzerland. The...